Resonant Capital Advisors’s Elanco Animal Health ELAN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$763K	Buy	31,892 +139	+0.4%	+$3.4K	0.04%	206
2025 Q4	$719K	Sell	31,753 -1,070	-3%	-$23.3K	0.04%	200
2025 Q3	$661K	Buy	32,823 +1,090	+3%	+$18.3K	0.04%	209
2025 Q2	$453K	Buy	31,733 +2,319	+8%	+$27.1K	0.03%	251
2025 Q1	$309K	Buy	29,414 +1,576	+6%	+$17.8K	0.02%	280
2024 Q4	$337K	Buy	27,838 +266	+1%	+$3.48K	0.02%	251
2024 Q3	$405K	Buy	27,572 +247	+0.9%	+$3.44K	0.03%	227
2024 Q2	$394K	Buy	27,325 +1,306	+5%	+$20.9K	0.03%	224
2024 Q1	$424K	Buy	26,019 +230	+0.9%	+$3.6K	0.04%	217
2023 Q4	$384K	Buy	25,789 +4,172	+19%	+$47.3K	0.04%	206
2023 Q3	$243K	Buy	21,617 +833	+4%	+$9.67K	0.03%	241
2023 Q2	$209K	Buy	20,784 +1,028	+5%	+$9.54K	0.02%	258
2023 Q1	$186K	Buy	19,756 +432	+2%	+$5.1K	0.02%	248
2022 Q4	$236K	Buy	+19,324	New	+$241K	0.03%	233
2022 Q2	–	Sell	-14,294	Closed	-$373K	–	240
2022 Q1	$373K	Buy	14,294 +614	+4%	+$16.4K	0.06%	165
2021 Q4	$388K	Buy	13,680 +1,174	+9%	+$36.5K	0.06%	153
2021 Q3	$399K	Buy	12,506 +2,266	+22%	+$76K	0.07%	145
2021 Q2	$355K	Buy	10,240 +275	+3%	+$9.07K	0.07%	143
2021 Q1	$293K	Buy	9,965 +130	+1%	+$4K	0.06%	151
2020 Q4	$302K	Buy	9,835 +422	+4%	+$12.9K	0.07%	149
2020 Q3	$263K	Sell	9,413 -1,530	-14%	-$38.8K	0.08%	138
2020 Q2	$235K	Sell	10,943 -5,534	-34%	-$122K	0.07%	163
2020 Q1	$369K	Buy	16,477 +1,096	+7%	+$30K	0.13%	147
2019 Q4	$453K	Buy	+15,381	New	+$418K	0.14%	152